Dr. Reginald R. Cooper, UI CCOM
professor and emeritus head of orthopaedics at UI Hospitals and
Clinics, will receive a prestigious national award for his lifetime
contributions to the field of orthopaedics. The American Orthopaedic
Association-Zimmer Award for Distinguished Contribution to Orthopaedics
will be presented to Cooper in June during the association's annual
meeting in Huntington Beach, Calif.
The $50,000 award recognizes outstanding leadership in the advancement
of the art and science of orthopaedics. It is bestowed on individuals
who effectively confront issues or challenges facing the specialty and
honors those who have enhanced and shaped the specialty. It recognizes
sustained and substantial contributions and leadership to orthopaedic
surgery through clinical, educational, research or other meritorious
Cooper is only the fourth recipient of the AOA-Zimmer Award, and the
second from the UI to receive it. The previous UI winner was Dr.
Ignacio V. Ponseti, UI professor emeritus of orthopaedics, who received
the award in 2003.
A UI faculty member since 1962, Cooper served as head of the UI
Department of Orthopaedic Surgery for 26 years. During his career he
has served as president of the American Academy of Orthopaedic
Surgeons, the largest society of orthopaedic surgeons in the world. He
also presided over the Orthopaedic Research Society and has received
the Kappa Delta Award for outstanding orthopaedic research.
Cooper acted as chairman of the research advisory board and the medical
advisory board for the Shriner's Hospitals for Children. He served on
the advisory council of the National Institutes of Health for the
Institute of Arthritis, Metabolic and Digestive Diseases, and was
chairman of the board of trustees of the Journal of Bone and Joint
Dr. Al Klingelhutz, microbiology, recently served as a co-chair
of the Transformation and Carcinogenesis session of the 2004 Molecular
Biology of DNA Tumor Viruses Conference in Madison, Wis. Also, three
abstracts from his laboratory were chosen for oral presentations at the
Dr. Garry R. Buettner, radiation oncology, chaired
the special emphasis panel reviewing technology center grants for the
NIH in September.
Dr. Kevin Ault, obstetrics and gynecology, reports that the UI
is the leading site for the study “Herpevac Trial for Women,” a vaccine
trial sponsored by the National Institutes of Health. Ault and his team
enrolled the UI’s 200th patient in September, and hope to eventually
enroll 500 women. Overall enrollment for the trial is 7,500 patients at
30 sites around the country.
Dr. Nancy Stellwagen, biochemistry, is co-editor of the recently published book "Nucleic Acids: Curvature and Deformation."
Theresa Hegmann, physician assistant program,
was presented the "Rising Star Award" in recognition of her
contribution to physician assistant education through excellence in
teaching from the Association of Physician Assistant Programs.
Dr. Daniel T. Tranel,
professor of neurology, will serve as the invited chairperson of the
NIH Cognitive Neuroscience Study Section, Center for Scientific Review,
from now through June 2006.
Dr. Douglas Spitz, radiation
oncology, presented a seminar on cellular stress biology at Roswell
Park Cancer Institute on Sept. 30. He also served on the special study
section "DNA Damage and Mutagenesis" for the NIH and NCI.
Dr. Prabhat C. Goswami,
radiation oncology, was awarded a $20,000 pilot grant from the
Environmental Health Sciences Research Center. The one-year grant,
"Polychlorinated Biphenyls, Intracellular Antioxidants and Cellular
Proliferation," will test the hypothesis that polychlorinated biphenyls
(PCBs) affect reactive oxygen species in the cell, thus changing the
reduction/oxidative balance and initiating cellular proliferation.
Dr. Richard Tyler, professor of
otolaryngology and speech pathology and audiology, is directing
the largest clinical trial for tinnitus ever funded by the
government and is supported by a five-year, $1.7 million grant
from the National Institute on Deafness and Other Communication
Disorders, part of the NIH. The study examines approaches that combine
low-level background sounds, including music, with a new, extensive
counseling protocol.The low-level background sound decreases the
prominence of the tinnitus, but is not too loud to be annoying. The
counseling is designed to help with concentration, hearing and sleep
problems caused by the ringing.